Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis
Tóm tắt
Licensed for use in males in 2009, Human Papillomavirus (HPV) vaccination rates in adolescent males are extremely low. Literature on HPV vaccination focuses on females, adult males, or parents of adolescent males, without including adolescent males or the dynamics of the parent-son interaction that may influence vaccine decision-making. The purpose of this paper is to examine the decision-making process of parent-son dyads when deciding whether or not to get vaccinated against HPV. Twenty-one adolescent males (ages 13–17), with no previous HPV vaccination, and their parents/guardians were recruited from adolescent primary care clinics serving low to middle income families in a large Midwestern city. Dyad members participated in separate semi-structured interviews assessing the relative role of the parent and son in the decision regarding HPV vaccination. Interviews were recorded, transcribed, and coded using inductive content analysis. Parents and sons focused on protection as a reason for vaccination; parents felt a need to protect their child, while sons wanted to protect their own health. Parents and sons commonly misinterpreted the information about the vaccine. Sons were concerned about an injection in the penis, while some parents and sons thought the vaccine would protect them against other sexually transmitted infections including Herpes, Gonorrhea, and HIV. Parents and sons recalled that the vaccine prevented genital warts rather than cancer. The vaccine decision-making process was rapid and dynamic, including an initial reaction to the recommendation for HPV vaccine, discussion between parent and son, and the final vaccine decision. Provider input was weighed in instances of initial disagreement. Many boys felt that this was the first health care decision that they had been involved in. Dyads which reported shared decision-making were more likely to openly communicate about sexual issues than those that agreed the son made the decision. Parents and sons play an active role in the decision-making process, with an individual’s role being influenced by many factors. The results of this study may be used to guide the messages presented by clinicians when recommending the HPV vaccine, and future vaccine uptake interventions.
Tài liệu tham khảo
Centers for Disease Control and Prevention: Genital HPV Infection – Fact Sheet. http://www.cdc.gov/std/HPV/STDFact-HPV.htm (accessed 12/13/2012)
U S Food and Drug Administration: Product approval -- Licensing action: Gardasil(R). 2006, http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm096052.htm (accessed 12/13/2012)
Markowitz LE, Dunne E, Saraiya M, Lawson H, Chesson H, Unger E: Quadrivalent human papillomavirus vaccine. Morb Mortal Wkly Rep. 2007, 56 (RR02): 1-24.
US Food and Drug Administration: Gardasil Approval Letter. 2009, http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186991.htm (accessed 12/13/2012)
Centers for Disease Control and Prevention: FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010, 59: 630-632.
Centers for Disease Control and Prevention: National and state vaccination coverage among adolescents aged 13 through 17 years-United States 2010. MMWR. 2011, 60: 1117-1123.
Center for Disease Control and Prevention: Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011, 60 (50): 1705-1708.
Australian Government Department of Health and Ageing: HPV vaccine extended to boys. http://www.health.gov.au/internet/ministers/publishing.nsf/Content/59C397F61CACF02FCA257A390000C65A/$File/TP059.pdf. (accessed 12/13/2012)
Jones M, Cook R: Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health. 2008, 57 (1): 23-32. 10.3200/JACH.57.1.23-32.
Reiter PL, Brewer NT, Smith JS: Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men. Sex Transm Infect. 2010, 86 (3): 241-246. 10.1136/sti.2009.039065.
Reiter PL, Brewer NT, McRee AL, Gilbert P, Smith JS: Acceptability of HPV vaccine among a national sample of gay and bisexual men. Sex Transm Dis. 2010, 37 (3): 197-10.1097/OLQ.0b013e3181bf542c.
Gilbert P, Brewer NT, Reiter PL, Ng TW, Smith JS: HPV vaccine acceptability in heterosexual, gay, and bisexual men. Am J Mens Health. 2011, 5 (4): 297-10.1177/1557988310372802.
Gilbert PA, Brewer NT, Reiter PL: Association of human papillomavirus-related knowledge, attitudes, and beliefs with HIV status: a national study of gay men. J Low Genit Tract Dis. 2011, 15 (2): 83-10.1097/LGT.0b013e3181f1a960.
Reiter PL, McRee A-L, Gottlieb SL, Brewer NT: HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure. Vaccine. 2010, 28: 6292-6297. 10.1016/j.vaccine.2010.06.114.
Dempsey AF, Butchart A, Singer D, Clark S, Davis M: Factors associated with parental intentions for male human papillomavirus vaccination: results of a national survey. Sex Transm Dis. 2011, 38 (8): 769-776.
Reiter PL, McRee A-L, Kadis JA, Brewer NT: HPV vaccine and adolescent males. Vaccine. 2011, 29 (34): 5595-5602. 10.1016/j.vaccine.2011.06.020.
Perkins RB, Clark JA: Providers’ attitudes toward human papillomavirus vaccination in young men: challenges for implementation of 2011 recommendations. Am J Mens Health. 2012, 6 (4): 320-323. 10.1177/1557988312438911.
Forster AS, Marlow LA, Wardle J, Stephenson J, Waller J: Interest in having HPV vaccination among adolescent boys in England. Vaccine. 2012, 30 (30): 4505-4510. 10.1016/j.vaccine.2012.04.066.
Stupiansky NW, Alexander AB, Zimet GD: Human papillomavirus vaccine and men: what are the obstacles and challenges?. Curr Opin Infect Dis. 2012, 25 (1): 86-10.1097/QCO.0b013e32834ed5be.
Cox DS, Cox AD, Sturm L, Zimet G: Behavioral interventions to increase HPV vaccination acceptability among mothers of young girls. Health Psychol. 2010, 29 (1): 29-
Roberts ME, Gerrard M, Reimer R, Gibbons FX: Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics. 2010, 125 (5): 982-10.1542/peds.2009-2888.
Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD: Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician's recommendation. Vaccine. 2011, 29 (5): 890-895. 10.1016/j.vaccine.2009.12.063.
Gerend MA, Weibley E, Bland H: Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009, 45 (5): 528-531. 10.1016/j.jadohealth.2009.02.006.
Dempsey AF, Abraham LM, Dalton V, Ruffin M: Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol. 2009, 19 (8): 531-538. 10.1016/j.annepidem.2009.03.011.
Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, Kahn JA: Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health. 2009, 18 (10): 1679-1686. 10.1089/jwh.2008.1329.
Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD: Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol. 2008, 111 (5): 1103-1110. 1110.1097/AOG.1100b1013e31817051fa.
Zimet GD, Perkins SM, Sturm LA, Bair RM, Juliar BE, Mays RM: Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Health. 2005, 37 (3): 179-186. 10.1016/j.jadohealth.2005.06.004.
Hughes C, Jones A, Feemster K, Fiks A: HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr. 2011, 11 (1): 74-10.1186/1471-2431-11-74.
Elo S, Kyngäs H: The qualitative content analysis process. J Adv Nurs. 2008, 62 (1): 107-115. 10.1111/j.1365-2648.2007.04569.x.
Leader AE, Weiner JL, Kelly BJ, Hornik RC, Cappella JN: Effects of information framing on human papillomavirus vaccination. J Womens Health. 2009, 18 (2): 225-233. 10.1089/jwh.2007.0711.
Watts LA, Joseph N, Wallace M, Rauh-Hain JA, Muzikansky A, Growdon WB, del Carmen MG: HPV vaccine: a comparison of attitudes and behavioral perspectives between latino and non-latino women. Gynecol Oncol. 2009, 112 (3): 577-582. 10.1016/j.ygyno.2008.12.010.
Ferris DG, Waller JL, Miller J, Patel P, Jackson L, Price GA, Wilson C: Men’s Attitudes toward receiving the human papillomavirus vaccine. J Low Genit Tract Dis. 2008, 12 (4): 276-281. 210.1097/LGT.1090b1013e318167913e.
Benin AL, Wu AC, Holmboe ES, Shapiro ED, Anyan W: How can we communicate about vaccines with adolescents and their parents?. Clin Pediatr. 2010, 49 (4): 373-380. 10.1177/0009922809351091.
Brabin L, Roberts SA, Farzaneh F, Kitchener HC: Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine. 2006, 24 (16): 3087-3094. 10.1016/j.vaccine.2006.01.048.
Juliar BE, Bair RM, Zimet GD, Sturm LA, Mays RM, Perkins SM: Concordance in decision making for STD vaccination between parents and adolescents. 2006, Jacksonville, FL: National STD Prevention Conference
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/12/192/prepub